PhytoBioSystems
Executive Summary
A University of Massachusetts spin-off, PhytoBioSystems will develop plant extract products that will boost human disease resistance as well as provide a means of natural food preservation.
You may also be interested in...
US High Court Punts On ‘Objective Falsity’ FCA Standard
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
Warning Letter Close-Outs – February 2021
No device-related close-out letters were released by the US FDA last month.
EU Launches ‘Structured Dialog’ To Thrash Out Supply Chain Concerns
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports